Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 5,387 TARS shares, $457.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 5,387 | $457.9K |
| Sep 3, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 4,601 | $339.8K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 375 | $26.0K |
| Mar 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,511 | n/a |
| Mar 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 27,310 | n/a |
| Dec 17, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 6,819 | n/a |
| Jun 20, 2025 | STAAR SURGICAL CO (STAA) | Grant/Award | 5,341 | n/a |
| Jun 17, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |
| Mar 7, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 15,314 | n/a |
| Nov 6, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 41,074 | n/a |